Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-13-038318
Filing Date
2013-05-07
Accepted
2013-05-07 17:39:42
Documents
1
Period of Report
2013-04-25

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 9133
  Complete submission text file 0001104659-13-038318.txt   10497
Mailing Address C/O ALNYLAM PHARMACEUTICALS, INC 300 THIRD STREET CAMBRIDGE MA 02142
Business Address
Westphal Christoph H (Reporting) CIK: 0001291961 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35403 | Film No.: 13821478

Mailing Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142 617-252-9300
Verastem, Inc. (Issuer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations